Stimulation of Renin Release by 6-oxo-prostaglandin E1 and Prostacyclin
Overview
Authors
Affiliations
1 Renin release induced by 6-oxo-prostaglandin E1 (6-oxo-PGE1) was compared to release in response to prostacyclin (PGI2) and 6-oxo-PGF1 alpha in slices of rabbit renal cortex. 2 Krebs-Ringer medium bathing slices of renal cortex was collected for renin assay after four successive 20 min intervals (periods I-IV). Renin release did not increase during periods I to IV in untreated slices. Agonists were added, only once, at the beginning of period III. Between periods III and IV, the incubation solution was aspirated and replaced with fresh medium. 3 PGI2 increased renin release during period III while 6-oxo-PGE1 stimulated release during periods III and IV. 6-oxo-PGE1 stimulated renin release (24%-74%) in concentrations ranging from 1-33 microM while PGI2 stimulated release at 10 microM (60%) but not at 5 microM. 6-oxo-PGF1 alpha, 10 microM, did not release renin during period III (period III, 9%), but caused a small rise in period IV (29%). 4 6-oxo-PGE1, unlike PGI2, was stable under the incubation conditions (pH 7.4, 37 degrees C) as indicated by recovery of undiminished platelet anti-aggregatory material after 20 min. 5 In the rabbit kidney, activity of 9-hydroxyprostaglandin dehydrogenase was greatest in the cortex and negligible in the papilla, corresponding to the zonal distribution of renin. 6 The prominent and sustained in vitro renin releasing effect of 6-oxo-PGE1, as well as the cortical localization of enzyme activity capable of generating this stable prostacyclin metabolite, suggest that formation of 6-oxo-PGE1 may contribute to PGI2-induced renin release and may explain the delayed stimulation caused by 6-oxo-PGF1 alpha.
Frusemide releases renin in the rat kidney when prostacyclin synthesis is suppressed.
Barden A, Mahoney D, Tunney A, VANDONGEN R Br J Pharmacol. 1984; 82(2):493-9.
PMID: 6375797 PMC: 1987040. DOI: 10.1111/j.1476-5381.1984.tb10785.x.
Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
Griffiths R, Moore P Br J Pharmacol. 1983; 80(2):395-402.
PMID: 6360281 PMC: 2045025. DOI: 10.1111/j.1476-5381.1983.tb10046.x.
Formation of 6-keto prostaglandin E1 in mammalian kidneys.
Griffiths R, Moore P Br J Pharmacol. 1983; 79(1):149-55.
PMID: 6347300 PMC: 2044815. DOI: 10.1111/j.1476-5381.1983.tb10507.x.
Identification of 6-oxo-prostaglandin E1 as a naturally occurring prostanoid generated by rat lung.
Berry C, Griffiths R, Hoult J, Moore P, Taylor G Br J Pharmacol. 1986; 87(2):327-35.
PMID: 3955304 PMC: 1916551. DOI: 10.1111/j.1476-5381.1986.tb10821.x.
Miyamori I, Morise T, Yasuhara S, Takeda Y, Koshida H, Takeda R Br J Clin Pharmacol. 1985; 20(6):681-3.
PMID: 3912001 PMC: 1400843. DOI: 10.1111/j.1365-2125.1985.tb05128.x.